S M Skevington1, A Wright. 1. WHO Centre for the Study of Quality of Life, Department of Psychology, University of Bath, Bath BA2 7AY. s.m.skevington@bath.ac.uk
Abstract
BACKGROUND: The study arises from the need for good quality of life (QOL) assessment and a new comprehensive generic QOL profile for cross-cultural use. AIMS: To examine changes in the QOL of patients receiving antidepressants from a general practitioner, and to assess the validity and sensitivity of a new QOL measure, the World Health Organization Quality of Life Assessment (100-item version) (WHOQOL-100). METHOD: Patients with moderate depression (n = 106) completed the WHOQOL-100 and Beck Depression Inventory at the start of treatment and again after 6 weeks. RESULTS: Depression decreased significantly over 2 months and 74% reported feeling better. WHOQOL-100 scores increased in 24 of the 25 facets, demonstrating that QOL improves significantly in the 8 weeks following the start of antidepressant treatment. It also shows the instrument's validity and sensitivity to changes in clinical condition. CONCLUSIONS: The UK WHOQOL-100 is confirmed as excellent to good. Antidepressants significantly and comprehensively improve QOL.
BACKGROUND: The study arises from the need for good quality of life (QOL) assessment and a new comprehensive generic QOL profile for cross-cultural use. AIMS: To examine changes in the QOL of patients receiving antidepressants from a general practitioner, and to assess the validity and sensitivity of a new QOL measure, the World Health Organization Quality of Life Assessment (100-item version) (WHOQOL-100). METHOD:Patients with moderate depression (n = 106) completed the WHOQOL-100 and Beck Depression Inventory at the start of treatment and again after 6 weeks. RESULTS:Depression decreased significantly over 2 months and 74% reported feeling better. WHOQOL-100 scores increased in 24 of the 25 facets, demonstrating that QOL improves significantly in the 8 weeks following the start of antidepressant treatment. It also shows the instrument's validity and sensitivity to changes in clinical condition. CONCLUSIONS: The UK WHOQOL-100 is confirmed as excellent to good. Antidepressants significantly and comprehensively improve QOL.
Authors: Fons J Trompenaars; Erik D Masthoff; Guus L Van Heck; Paul P Hodiamont; Jolanda De Vries Journal: Qual Life Res Date: 2005-02 Impact factor: 4.147
Authors: Jenny X Zhang; Jennifer D Walker; Walter P Wodchis; David B Hogan; David H Feeny; Colleen J Maxwell Journal: Qual Life Res Date: 2006-06-22 Impact factor: 4.147
Authors: Erik D Masthoff; Fons J Trompenaars; Guus L Van Heck; Helen J Michielsen; Paul P Hodiamont; Jolanda De Vries Journal: Qual Life Res Date: 2006-11-08 Impact factor: 4.147
Authors: Martin Aigner; Sophie Förster-Streffleur; Wolfgang Prause; Marion Freidl; Maria Weiss; Michael Bach Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2006-01-01 Impact factor: 4.328
Authors: Tara M Brinkman; Nicole J Ullrich; Nan Zhang; Daniel M Green; Lonnie K Zeltzer; Karen M Lommel; Pim Brouwers; Deo Kumar Srivastava; Neelam Jain; Leslie L Robison; Kevin R Krull Journal: J Cancer Surviv Date: 2012-12-08 Impact factor: 4.442
Authors: Waguih William IsHak; Michael Davis; Jessica Jeffrey; Konstantin Balayan; Robert N Pechnick; Kara Bagot; Mark Hyman Rapaport Journal: Curr Psychiatry Rep Date: 2009-12 Impact factor: 5.285